These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 33673227)

  • 21. Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini.
    Sitthirach C; Charoensuk L; Pairojkul C; Chaidee A; Intuyod K; Pongking T; Thongpon P; Jantawong C; Hongsrichan N; Waraasawapati S; Yingklang M; Pinlaor S
    PLoS One; 2022; 17(9):e0275273. PubMed ID: 36166461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
    Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model.
    Mishra A; Arindkar S; Sahay P; Kumar JM; Upadhyay PK; Majumdar SS; Nagarajan P
    Int J Exp Pathol; 2018 Feb; 99(1):46-53. PubMed ID: 29656466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
    Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.
    Jensen VS; Hvid H; Damgaard J; Nygaard H; Ingvorsen C; Wulff EM; Lykkesfeldt J; Fledelius C
    Diabetol Metab Syndr; 2018; 10():4. PubMed ID: 29410708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of ApoA5 aggravates spontaneous and diet-induced nonalcoholic fatty liver disease by reducing hepatic NR1D1 in hamsters.
    Guo J; Miao G; Zhang W; Shi H; Lai P; Xu Y; Zhang L; Chen G; Han Y; Zhao Y; Liu G; Zhang L; Wang Y; Huang W; Xian X
    Theranostics; 2024; 14(5):2036-2057. PubMed ID: 38505614
    [No Abstract]   [Full Text] [Related]  

  • 29. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose.
    Kweon SM; Irimia-Dominguez J; Kim G; Fueger PT; Asahina K; Lai KK; Allende DS; Lai QR; Lou CH; Tsark WM; Yang JD; Ng DS; Lee JS; Tso P; Huang W; Lai KKY
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G147-G157. PubMed ID: 37129245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis.
    Ichimura M; Masuzumi M; Kawase M; Sakaki M; Tamaru S; Nagata Y; Tanaka K; Suruga K; Tsuneyama K; Matsuda S; Omagari K
    J Nutr Biochem; 2017 Feb; 40():62-69. PubMed ID: 27863346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbon tetrachloride (CCl
    Zhang G; Wang X; Chung TY; Ye W; Hodge L; Zhang L; Chng K; Xiao YF; Wang YJ
    BMC Gastroenterol; 2020 Oct; 20(1):339. PubMed ID: 33059584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].
    Nakajima T; Naito H
    Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver.
    Igreja Sá IC; Tripska K; Hroch M; Hyspler R; Ticha A; Lastuvkova H; Schreiberova J; Dolezelova E; Eissazadeh S; Vitverova B; Najmanova I; Vasinova M; Pericacho M; Micuda S; Nachtigal P
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.
    Henkel J; Coleman CD; Schraplau A; Jӧhrens K; Weber D; Castro JP; Hugo M; Schulz TJ; Krämer S; Schürmann A; Püschel GP
    Mol Med; 2017 May; 23():70-82. PubMed ID: 28332698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet.
    Jang SA; Lee S; Sohn EH; Yang J; Park DW; Jeong YJ; Kim I; Kwon JE; Song HS; Cho YM; Meng X; Koo HJ; Kang SC
    Nutr Res; 2016 Sep; 36(9):914-924. PubMed ID: 27632911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet.
    Fouret G; Gaillet S; Lecomte J; Bonafos B; Djohan F; Barea B; Badia E; Coudray C; Feillet-Coudray C
    Br J Nutr; 2018 Feb; 119(4):368-380. PubMed ID: 29498345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.